Terms: = Leukemia AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C
67 results:
1. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.
Kalmbach S; Grau M; Zapukhlyak M; Leich E; Jurinovic V; Hoster E; Staiger AM; Kurz KS; Weigert O; Gaitzsch E; Passerini V; Engelhard M; Herfarth K; Beiske K; Micci F; Möller P; Bernd HW; Feller AC; Klapper W; Stein H; Hansmann ML; Hartmann S; Dreyling M; Holte H; Lenz G; Rosenwald A; Ott G; Horn H;
Leukemia; 2023 Oct; 37(10):2058-2065. PubMed ID: 37563306
[TBL] [Abstract] [Full Text] [Related]
2. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
3. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
[TBL] [Abstract] [Full Text] [Related]
4. A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.
Wagner A; Rouleau M; Villeneuve L; Le T; Peltier C; Allain ÉP; Beaudoin C; Tremblay S; Courtier F; Nguyen Van Long F; Laverdière I; Lévesque É; Banerji V; Vanura K; Guillemette C
Cells; 2023 May; 12(9):. PubMed ID: 37174695
[TBL] [Abstract] [Full Text] [Related]
5. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
Nejati R; Amador C; Czader M; Thacker E; Thakkar D; Dave SS; Dogan A; Duffield A; Goodlad JR; Ott G; Wasik MA; Xiao W; Cook JR
Am J Clin Pathol; 2023 Jun; 159(6):598-613. PubMed ID: 37085150
[TBL] [Abstract] [Full Text] [Related]
6. IL-4, IL-13 and IFN-γ -induced genes in highly purified human neutrophils.
Kummola L; Salomaa T; Ortutay Z; Savan R; Young HA; Junttila IS
Cytokine; 2023 Apr; 164():156159. PubMed ID: 36809715
[TBL] [Abstract] [Full Text] [Related]
7. Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity
Kaneshige A; Bai L; Wang M; McEachern D; Meagher JL; Xu R; Kirchhoff PD; Wen B; Sun D; Stuckey JA; Wang S
J Med Chem; 2023 Feb; 66(4):2717-2743. PubMed ID: 36735833
[TBL] [Abstract] [Full Text] [Related]
8. JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL.
Haselager MV; Thijssen R; Bax D; Both D; De Boer F; Mackay S; Dubois J; Mellink C; Kater AP; Eldering E
Mol Oncol; 2023 Jun; 17(6):1112-1128. PubMed ID: 36550750
[TBL] [Abstract] [Full Text] [Related]
9. JAK: Not Just Another Kinase.
Agashe RP; Lippman SM; Kurzrock R
Mol Cancer Ther; 2022 Dec; 21(12):1757-1764. PubMed ID: 36252553
[TBL] [Abstract] [Full Text] [Related]
10. Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target.
Wadood A; Ajmal A; Junaid M; Rehman AU; Uddin R; Azam SS; Khan AZ; Ali A
Curr Pharm Des; 2022; 28(36):3023-3032. PubMed ID: 35909285
[TBL] [Abstract] [Full Text] [Related]
11. PARP14 is a novel target in stat6 mutant follicular lymphoma.
Mentz M; Keay W; Strobl CD; Antoniolli M; Adolph L; Heide M; Lechner A; Haebe S; Osterode E; Kridel R; Ziegenhain C; Wange LE; Hildebrand JA; Shree T; Silkenstedt E; Staiger AM; Ott G; Horn H; Szczepanowski M; Richter J; Levy R; Rosenwald A; Enard W; Zimber-Strobl U; von Bergwelt-Baildon M; Hiddemann W; Klapper W; Schmidt-Supprian M; Rudelius M; Bararia D; Passerini V; Weigert O
Leukemia; 2022 Sep; 36(9):2281-2292. PubMed ID: 35851155
[TBL] [Abstract] [Full Text] [Related]
12. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
Mosquera Orgueira A; Ferreiro Ferro R; Díaz Arias JÁ; Aliste Santos C; Antelo Rodríguez B; Bao Pérez L; Alonso Vence N; Bendaña López Á; Abuin Blanco A; Melero Valentín P; Peleteiro Raindo AR; Cid López M; Pérez Encinas MM; González Pérez MS; Fraga Rodríguez MF; Bello López JL
PLoS One; 2021; 16(5):e0248886. PubMed ID: 33945543
[TBL] [Abstract] [Full Text] [Related]
13. Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis.
Traxel S; Lehmann J; Richard S; Sidorov S; Niggli F; Berger C; Nadal D; Bürgler S
Cancer Immunol Immunother; 2021 Aug; 70(8):2275-2289. PubMed ID: 33507341
[TBL] [Abstract] [Full Text] [Related]
14. Traditional Chinese medicine compound, Bu Sheng Hui Yang Fang, promotes the proliferation of lymphocytes in the immunosuppressed mice potentially by upregulating IL-4 signaling.
Wang Y; Tan J; Hu P; Pei Q; Wen Y; Ma W; Shi K; Li Z; Li H; Cheng F; Gu X; Yao X; Man Y; Zhao R; Feng S; Ding X; Yang T
Biomed Pharmacother; 2021 Feb; 134():111107. PubMed ID: 33341059
[TBL] [Abstract] [Full Text] [Related]
15. Immunorelated gene polymorphisms associated with acute myeloid leukemia.
Liu Q; Hua M; Yan S; Zhang C; Wang R; Yang X; Han F; Hou M; Ma D
Clin Exp Immunol; 2020 Sep; 201(3):266-278. PubMed ID: 32349161
[TBL] [Abstract] [Full Text] [Related]
16. Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia.
Forthun RB; Hellesøy M; Sulen A; Kopperud RK; Sjøholt G; Bruserud Ø; McCormack E; Gjertsen BT
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1729-1749. PubMed ID: 31111215
[TBL] [Abstract] [Full Text] [Related]
17. BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.
Schleiss C; Ilias W; Tahar O; Güler Y; Miguet L; Mayeur-Rousse C; Mauvieux L; Fornecker LM; Toussaint E; Herbrecht R; Bertrand F; Maumy-Bertrand M; Martin T; Fournel S; Georgel P; Bahram S; Vallat L
Sci Rep; 2019 Jan; 9(1):701. PubMed ID: 30679590
[TBL] [Abstract] [Full Text] [Related]
18. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract] [Full Text] [Related]
19. The transcription factor stat6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes.
Leslie KA; Russell MA; Taniguchi K; Richardson SJ; Morgan NG
Diabetologia; 2019 Jan; 62(1):87-98. PubMed ID: 30338340
[TBL] [Abstract] [Full Text] [Related]
20. Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of stat6 and PDAP1.
Weston VJ; Wei W; Stankovic T; Kearns P
Exp Hematol; 2018 Jul; 63():52-63.e5. PubMed ID: 29656114
[TBL] [Abstract] [Full Text] [Related]
[Next]
